Correlation Between Handa Pharmaceuticals and Swancor Holding

Can any of the company-specific risk be diversified away by investing in both Handa Pharmaceuticals and Swancor Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Handa Pharmaceuticals and Swancor Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Handa Pharmaceuticals and Swancor Holding Co, you can compare the effects of market volatilities on Handa Pharmaceuticals and Swancor Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Handa Pharmaceuticals with a short position of Swancor Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Handa Pharmaceuticals and Swancor Holding.

Diversification Opportunities for Handa Pharmaceuticals and Swancor Holding

0.86

Correlation Coefficient

Handa Pharmaceuticals  Swancor Holding

Very poor diversification

The 3 months correlation between Handa and Swancor is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Handa Pharmaceuticals and Swancor Holding Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Swancor Holding and Handa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Handa Pharmaceuticals are associated (or correlated) with Swancor Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Swancor Holding has no effect on the direction of Handa Pharmaceuticals i.e., Handa Pharmaceuticals and Swancor Holding go up and down completely randomly.

Pair Corralation between Handa Pharmaceuticals and Swancor Holding

Assuming the 90 days trading horizon Handa Pharmaceuticals is expected to under-perform the Swancor Holding. But the stock apears to be less risky and, when comparing its historical volatility, Handa Pharmaceuticals is 1.11 times less risky than Swancor Holding. The stock trades about -0.32 of its potential returns per unit of risk. The Swancor Holding Co is currently generating about -0.17 of returns per unit of risk over similar time horizon. If you would invest  10,050  in Swancor Holding Co on September 15, 2024 and sell it today you would lose (890.00) from holding Swancor Holding Co or give up 8.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	95.65%
Values	Daily Returns

Handa Pharmaceuticals  vs.  Swancor Holding Co

Handa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Handa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Swancor Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Swancor Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Handa Pharmaceuticals and Swancor Holding

The main advantage of trading using opposite Handa Pharmaceuticals and Swancor Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Handa Pharmaceuticals position performs unexpectedly, Swancor Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Swancor Holding will offset losses from the drop in Swancor Holding's long position.

The idea behind Handa Pharmaceuticals and Swancor Holding Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.